Travere Therapeutics, Inc. Common Stock (TVTX) is a publicly traded Healthcare sector company. As of October 12, 2026, TVTX trades at $52.01 with a market cap of $4.91B and a P/E ratio of -195.24. TVTX moved -0.24% today. Year to date, TVTX is +36.14%; over the trailing twelve months it is +106.76%. Its 52-week range spans $12.91 to $68.73. Analyst consensus is strong buy with an average price target of $75.92. Rallies surfaces TVTX's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
12 analysts cover TVTX: 0 strong buy, 11 buy, 1 hold, 0 sell, and 0 strong sell. The consensus rating is strong buy. The average price target is $75.92.
| Metric | Value |
|---|---|
| Price | $52.01 |
| Market Cap | $4.91B |
| P/E Ratio | -195.24 |
| EPS | $-0.29 |
| Dividend Yield | 0.00% |
| 52-Week High | $68.73 |
| 52-Week Low | $12.91 |
| Volume | 874.55K |
| Avg Volume | 0 |
| Revenue (TTM) | $490.73M |
| Net Income | $-25.55M |
| Gross Margin | 97.89% |
12 analysts cover TVTX: 0 strong buy, 11 buy, 1 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $75.92.